This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Cardiovascular
Milrinone and dobutamine equally effective in cardiogenic shock
Read more
Echocardiographic parameters identify mortality risk in COVID-19
Read more
Elevated low-density lipoprotein in childhood highlights the need for early risk screening
Read more
Increased cancer risk among those with heart failure
Read more
Oral anticoagulants use of limited value in COVID-19
Read more
Greater fruit intake associated with lower risk of diabetes
Read more
CGM associated with better control in type 2 diabetics receiving basal insulin
Read more
MicroRNAs can distinguish between myocarditis and myocardial infarction
Read more
Smartphone app leads to weight loss in Asian adults with type 2 diabetes
Read more
Troponin I levels prognostic for more severe disease in COVID-19
Read more
Wearable devices can accurately predict clinical laboratory measurements
Read more
Thiazide diuretic use associated with increased risk of skin cancer in older adults
Read more
Omega-3 supplements reduce markers of inflammation in response to stress
Read more
Risk of severe COVID-19 increased by physical inactivity
Read more
Higher levels of UVA associated with lower COVID-19 mortality
Read more
Working extended hours increases the risk of recurrent cardiovascular events
Read more
AI system detects appropriate self-medication with insulin and inhalers
Read more
Page 19 of 39
« First
«
...
10
...
17
18
19
20
21
...
30
...
»
Last »
Popular articles
Third of patients in favour of AI-supported consultations and clinical documents, study finds
18 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: